Unfortunately, it has nothing to do with XIN. Under the Chinese system, whether the shareholder actually owns anything is suspect. Until China can prove the ability to run a modern financial market, the shareholder is stuck with this dismal valuation.
Perhaps this might mean something: http://www.bloomberg.com/news/2013-02-25/sinopec-to-buy-chesapeake-oil-and-gas-assets-for-1-02-billion.html?cmpid=yhoo
"The BBRY stock now has 7 bearish to 0 bullish indicators in the short term time frame," says Will Peters, our resident technical specialist.
The Friday close saw a bearish Williams %R signals and a negative weekly Momentum signal being added to the existing negative indicators.
An analysis of the stock conducted by Trading Central shows analysts to be calling for a the next downside target at 9.5; this as long as the pivot level at 17 is not breached.
"The RSI is below 50. The MACD is positive and below its signal line. The MACD must penetrate its zero line to expect further downside. Moreover, the stock is trading under its 20 day MA (15.57) but above its 50 day MA (13.92)," say Trading Central.
That's better than the $80.71 million expected by Thomson Reuters analysts, and shares in Seattle-based Dendreon (NASDAQ: DNDN)
Sentiment: Strong Buy
There are many labs that can make fibroblasts and I am sure they can speed up the process. Just look at any biotech. I hope you are right. I am in since the LaViv bubble at $1.20.